BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kane JK, Tanaka H, Parker SL, Yanagisawa M, Li MD. Sensitivity of orexin-A binding to phospholipase C inhibitors, neuropeptide Y, and secretin. Biochem Biophys Res Commun 2000;272:959-65. [PMID: 10860858 DOI: 10.1006/bbrc.2000.2880] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Sahu A. Interactions of neuropeptide Y, hypocretin-I (orexin A) and melanin-concentrating hormone on feeding in rats. Brain Research 2002;944:232-8. [DOI: 10.1016/s0006-8993(02)02941-4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Kim H, Hong E, Kim J, Lee W. Solution Structure of Human Orexin-A: Regulator of Appetite and Wakefulness. BMB Reports 2004;37:565-73. [DOI: 10.5483/bmbrep.2004.37.5.565] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
3 Vogel V, Sanchez C, Jennum P. EEG measurements by means of radiotelemetry after intracerebroventricular (ICV) cannulation in rodents. Journal of Neuroscience Methods 2002;118:89-96. [DOI: 10.1016/s0165-0270(02)00148-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
4 Parker MS, Lundell I, Parker SL. Pancreatic polypeptide receptors: affinity, sodium sensitivity and stability of agonist binding 1 1Abbreviations: NPY, neuropeptide Y; hNPY, human NPY; PYY, peptide YY; pPYY, porcine PYY; LP-PYY, (Leu31,Pro34) human peptide YY; hPP, rPP, human and rat pancreatic polypeptide, respectively; hPYY [3–36], human peptide YY [3–36]; EIPA, 5-(N-ethyl, N-isopropyl)amiloride; DMA, 5-(N, N-dimethyl)amiloride; HEXA, 5-(N, N-hexamethylene)amiloride; MIA, 5-N(methyl, N-isobutyl)amiloride; CHO, Chinese hamster ovary; PEG, polyethylene glycol. Peptides 2002;23:291-303. [DOI: 10.1016/s0196-9781(01)00610-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
5 Aracri P, Banfi D, Pasini ME, Amadeo A, Becchetti A. Hypocretin (orexin) regulates glutamate input to fast-spiking interneurons in layer V of the Fr2 region of the murine prefrontal cortex. Cereb Cortex 2015;25:1330-47. [PMID: 24297328 DOI: 10.1093/cercor/bht326] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
6 Kane J, Parker S, Li M. Hypothalamic orexin-A binding sites are downregulated by chronic nicotine treatment in the rat. Neuroscience Letters 2001;298:1-4. [DOI: 10.1016/s0304-3940(00)01730-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
7 Shirasaka T, Kunitake T, Takasaki M, Kannan H. Neuronal effects of orexins: relevant to sympathetic and cardiovascular functions. Regul Pept 2002;104:91-5. [PMID: 11830282 DOI: 10.1016/s0167-0115(01)00352-4] [Cited by in Crossref: 62] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
8 Smart D, Haynes AC, Williams G, Arch JR. Orexins and the treatment of obesity. Eur J Pharmacol 2002;440:199-212. [PMID: 12007536 DOI: 10.1016/s0014-2999(02)01429-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
9 Jöhren O, Neidert SJ, Kummer M, Dendorfer A, Dominiak P. Prepro-Orexin and Orexin Receptor mRNAs Are Differentially Expressed in Peripheral Tissues of Male and Female Rats. Endocrinology 2001;142:3324-31. [DOI: 10.1210/endo.142.8.8299] [Cited by in Crossref: 133] [Cited by in F6Publishing: 144] [Article Influence: 6.3] [Reference Citation Analysis]
10 Li MD, Parker SL, Kane JK. Regulation of feeding-associated peptides and receptors by nicotine. Mol Neurobiol 2000;22:143-65. [PMID: 11414277 DOI: 10.1385/MN:22:1-3:143] [Cited by in Crossref: 44] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
11 Shu Q, Hu ZL, Huang C, Yu XW, Fan H, Yang JW, Fang P, Ni L, Chen JG, Wang F. Orexin-A promotes cell migration in cultured rat astrocytes via Ca2+-dependent PKCα and ERK1/2 signals. PLoS One 2014;9:e95259. [PMID: 24748172 DOI: 10.1371/journal.pone.0095259] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
12 Caillol M, Aïoun J, Baly C, Persuy MA, Salesse R. Localization of orexins and their receptors in the rat olfactory system: possible modulation of olfactory perception by a neuropeptide synthetized centrally or locally. Brain Res 2003;960:48-61. [PMID: 12505657 DOI: 10.1016/s0006-8993(02)03755-1] [Cited by in Crossref: 60] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
13 Smith MS, Grove KL. Integration of the regulation of reproductive function and energy balance: lactation as a model. Front Neuroendocrinol 2002;23:225-56. [PMID: 12127305 DOI: 10.1016/s0091-3022(02)00002-x] [Cited by in Crossref: 124] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
14 Parker SL, Parker MS, Sah R, Sallee F. Angiogenesis and rhodopsin-like receptors: a role for N-terminal acidic residues? Biochem Biophys Res Commun 2005;335:983-92. [PMID: 16023616 DOI: 10.1016/j.bbrc.2005.06.158] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
15 Holmqvist T, Åkerman KE, Kukkonen JP. High specificity of human orexin receptors for orexins over neuropeptide Y and other neuropeptides. Neuroscience Letters 2001;305:177-80. [DOI: 10.1016/s0304-3940(01)01839-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
16 Volkoff H, Peter RE. Interactions between orexin A, NPY and galanin in the control of food intake of the goldfish, Carassius auratus. Regulatory Peptides 2001;101:59-72. [DOI: 10.1016/s0167-0115(01)00261-0] [Cited by in Crossref: 94] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
17 Spinazzi R, Andreis PG, Rossi GP, Nussdorfer GG. Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol Rev. 2006;58:46-57. [PMID: 16507882 DOI: 10.1124/pr.58.1.4] [Cited by in Crossref: 112] [Cited by in F6Publishing: 107] [Article Influence: 7.0] [Reference Citation Analysis]
18 Smart D, Jerman JC. The physiology and pharmacology of the orexins. Pharmacology & Therapeutics 2002;94:51-61. [DOI: 10.1016/s0163-7258(02)00171-7] [Cited by in Crossref: 69] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
19 Langmead CJ, Jerman JC, Brough SJ, Scott C, Porter RA, Herdon HJ. Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor. Br J Pharmacol 2004;141:340-6. [PMID: 14691055 DOI: 10.1038/sj.bjp.0705610] [Cited by in Crossref: 110] [Cited by in F6Publishing: 94] [Article Influence: 5.8] [Reference Citation Analysis]
20 Kukkonen JP, Holmqvist T, Ammoun S, Åkerman KEO. Functions of the orexinergic/hypocretinergic system. American Journal of Physiology-Cell Physiology 2002;283:C1567-91. [DOI: 10.1152/ajpcell.00055.2002] [Cited by in Crossref: 200] [Cited by in F6Publishing: 188] [Article Influence: 10.0] [Reference Citation Analysis]
21 Smart D, Sabido-David C, Brough SJ, Jewitt F, Johns A, Porter RA, Jerman JC. SB-334867-A: the first selective orexin-1 receptor antagonist. Br J Pharmacol 2001;132:1179-82. [PMID: 11250867 DOI: 10.1038/sj.bjp.0703953] [Cited by in Crossref: 223] [Cited by in F6Publishing: 226] [Article Influence: 10.6] [Reference Citation Analysis]
22 Valiante S, Liguori G, Tafuri S, Campese R, Monaco R, Paino S, Laforgia V, Staiano N, Vittoria A. Expression of orexin A and its receptor 1 in the human prostate. J Anat 2013;222:473-80. [PMID: 23425077 DOI: 10.1111/joa.12030] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
23 Harris DM, Go VL, Reeve JR Jr, Wu SV. Stimulation of amylase release by Orexin is mediated by Orexin 2 receptor in AR42J cells. Pancreas 2002;25:405-10. [PMID: 12409837 DOI: 10.1097/00006676-200211000-00014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
24 Tam JK, Lau KW, Lee LT, Chu JY, Ng KM, Fournier A, Vaudry H, Chow BK. Origin of secretin receptor precedes the advent of tetrapoda: evidence on the separated origins of secretin and orexin. PLoS One 2011;6:e19384. [PMID: 21559418 DOI: 10.1371/journal.pone.0019384] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
25 Merten N, Lindner D, Rabe N, Römpler H, Mörl K, Schöneberg T, Beck-sickinger AG. Receptor Subtype-specific Docking of Asp6.59 with C-terminal Arginine Residues in Y Receptor Ligands. Journal of Biological Chemistry 2007;282:7543-51. [DOI: 10.1074/jbc.m608902200] [Cited by in Crossref: 65] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
26 Parker SL, Parker MS, Sah R, Balasubramaniam A, Sallee FR. Self-regulation of agonist activity at the Y receptors. Peptides 2007;28:203-13. [PMID: 17194507 DOI: 10.1016/j.peptides.2006.07.032] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
27 Jászberényi M, Bujdosó E, Telegdy G. The role of neuropeptide Y in orexin-induced hypothalamic-pituitary-adrenal activation. J Neuroendocrinol 2001;13:438-41. [PMID: 11328454 DOI: 10.1046/j.1365-2826.2001.00654.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
28 Wieland HA, Söll RM, Doods HN, Stenkamp D, Hurnaus R, Lämmle B, Beck-Sickinger AG. The SK-N-MC cell line expresses an orexin binding site different from recombinant orexin 1-type receptor. Eur J Biochem. 2002;269:1128-1135. [PMID: 11856342 DOI: 10.1046/j.0014-2956.2001.02739.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
29 Ammoun S, Holmqvist T, Shariatmadari R, Oonk HB, Detheux M, Parmentier M, Akerman KE, Kukkonen JP. Distinct recognition of OX1 and OX2 receptors by orexin peptides. J Pharmacol Exp Ther. 2003;305:507-514. [PMID: 12606634 DOI: 10.1124/jpet.102.048025] [Cited by in Crossref: 126] [Cited by in F6Publishing: 120] [Article Influence: 6.6] [Reference Citation Analysis]
30 Parker MS, Sah R, Balasubramaniam A, Sallee FR, Zerbe O, Parker SL. Non-specific binding and general cross-reactivity of Y receptor agonists are correlated and should importantly depend on their acidic sectors. Peptides 2011;32:258-65. [PMID: 21126552 DOI: 10.1016/j.peptides.2010.11.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
31 Kanenishi K, Ueno M, Momose S, Kuwabara H, Tanaka H, Sato C, Kobayashi T, Hino O, Sakamoto H, Hata T. Prepro-orexin mRNA expression in the rat brain is increased during pregnancy. Neuroscience Letters 2004;368:73-7. [DOI: 10.1016/j.neulet.2004.06.068] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]